Status:
UNKNOWN
Dual Perfusion Imaging for Characterizing Vascular Architecture of Brain Lesions
Lead Sponsor:
University Health Network, Toronto
Conditions:
Brain Tumor
Brain Metastases
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The objectives of the study are (1) to evaluate the feasibility of using a combined spin- and gradient- echo (SAGE) sequence in dynamic susceptibility contrast magnetic resonance imaging (DSC MRI) and...
Eligibility Criteria
Inclusion
- Diagnosed with a brain metastasis or primary brain tumour and who will undergo MRI with contrast.
Exclusion
- Subject or subject's legally authorized representative is unable or unwilling to consent to the study.
- Subject with documented contrast medium injection contraindication due to severe kidney disease or allergy.
Key Trial Info
Start Date :
September 24 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2024
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05358340
Start Date
September 24 2021
End Date
August 1 2024
Last Update
May 9 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Health Network
Toronto, Ontario, Canada, M5G 2C4